Introduction: Sever upper gastrointestinal bleeding (UGIB) is a life-threatening condition that often requires rapid and effective endoscopic intervention. Hemostatic powders offer a minimally invasive approach for bleeding control; however, cohesive powders such as CounterFlow can exhibit poor flowability through narrow catheters, increasing the risk of agglomeration, inconsistent dosing, and clogging. This study presents a simulation-guided approach for developing a novel pneumatic spray device for reliable endoscopic delivery of cohesive hemostatic powder.
Methods: The device consists of a funnel-shaped mixing chamber and a centrally positioned reciprocating sieve. Swirling gas flow suspends and disperses the powder, while the sieve regulates powder feeding and disrupts agglomerates before transport through the catheter. Computational fluid dynamics (CFD) simulations were performed in ANSYS Fluent to characterize swirling flow, pressure distribution, and particle transport inside the chamber. In parallel, ANSYS Rocky discrete element method (DEM) simulations were used to evaluate powder sifting behaviour and estimate the powder feeding rate into the swirling flow. Simulation results informed the selection of operating parameters, including gas flow rate and sieve oscillation frequency. Bench testing was then conducted under clinically relevant conditions to assess discharged gas volume, delivered powder mass, spray duration effects, and clog-free operation.
Results: The simulations identified key flow structures responsible for powder suspension and transport and demonstrated how sieve frequency influences powder feeding and dosing uniformity. Bench testing supported the computational findings and showed that the optimized prototype achieved consistent, controllable, and clog-free CounterFlow powder delivery.
Conclusions: CFD and DEM simulations provided critical insight into the coupled effects of swirling gas flow, powder sifting, and dosing control. This simulation-driven framework supports the development of reliable endoscopic spray devices for cohesive hemostatic powder delivery in UGIB treatment.